Expression of Egr1 and p53 in human carotid plaques and apoptosis induced by 7-oxysterol or p53

Experimental and Toxicologic Pathology

Volumn 65, Issue 5, 2013, Pages 677-682

  Miah, Sayem ^a,c   Zadeh, Shahram Nour Mohammad ^a   Yuan, Xi Ming ^a,b   Li, Wei ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

7 Oxysterols; Apoptosis; Atherosclerosis; Immediate early response protein (Egr 1); Nuclear fragmentation; P53

Indexed keywords

7 OXOCHOLESTEROL; 7BETA HYDROXYCHOLESTEROL; PROTEIN NOXA; PROTEIN P53; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; APOPTOSIS; ARTICLE; ATHEROGENESIS; BIOSYNTHESIS; CAROTID ATHEROSCLEROSIS; CELL LEVEL; CELL NUCLEUS; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID ANALYSIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

ANIMALS; APOPTOSIS; CAROTID STENOSIS; CELL CULTURE TECHNIQUES; EARLY GROWTH RESPONSE PROTEIN 1; HUMANS; HYDROXYCHOLESTEROLS; IMMUNOHISTOCHEMISTRY; KETOCHOLESTEROLS; MICE; REACTIVE OXYGEN SPECIES; TUMOR SUPPRESSOR PROTEIN P53; U937 CELLS;

EID: 84878358772     PISSN: 09402993     EISSN: 16181433     Source Type: Journal    
DOI: 10.1016/j.etp.2012.08.002     Document Type: Article

References (22)

1. Boone D.N., Qi Y., Li Z., Hann S.R. Egr1 mediates p53-independent c-Myc-induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:632-637.
2. de Belle I., Huang R.P., Fan Y., Liu C., Mercola D. Adamson ED. p53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis. Oncogene 1999, 18:3633-3642.
3. Guyton J.R., Lenz M.L., Mathews B., Hughes H., Karsan D., Selinger E., et al. Toxicity of oxidized low density lipoproteins for vascular smooth muscle cells and partial protection by antioxidants. Atherosclerosis 1995, 118:237-249.
4. Hasan R.N., Schafer A.I. Hemin upregulates Egr-1 expression in vascular smooth muscle cells via reactive oxygen species ERK-1/2-Elk-1 and NF-kappaB. Circulation Research 2008, 102:42-50.
5. Karaflou M., Lambrinoudaki I., Christodoulakos G. Apoptosis in atherosclerosis: a mini-review. Mini Reviews in Medicinal Chemistry 2008, 8:912-918.
6. Khachigian L.M. Early growth response-1 in cardiovascular pathobiology. Circulation Research 2006, 98:186-191.
7. Krones-Herzig A., Adamson E., Mercola D. Early growth response 1 protein, an upstream gatekeeper of the p53 tumor suppressor, controls replicative senescence. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:3233-3238.
8. Larsson D.A., Baird S., Nyhalah J.D., Yuan X.M., Li W. Oxysterol mixtures, in atheroma-relevant proportions, display synergistic and proapoptotic effects. Free Radical Biology and Medicine 2006, 41:902-910.
9. Li W., Dalen H., Eaton J.W., Yuan X.M. Apoptotic death of inflammatory cells in human atheroma. Arteriosclerosis, Thrombosis, and Vascular Biology 2001, 21:1124-1130.
10. Liu J., Grogan L., Nau M.M., Allegra C.J., Chu E., Wright J.J. Physical interaction between p53 and primary response gene Egr-1. International Journal of Oncology 2001, 18:863-870.
11. Lizard G., Monier S., Cordelet C., Gesquiere L., Deckert V., Gueldry S., et al. Characterization and comparison of the mode of cell death, apoptosis versus necrosis, induced by 7beta-hydroxycholesterol and 7-ketocholesterol in the cells of the vascular wall. Arteriosclerosis, Thrombosis, and Vascular Biology 1999, 19:1190-1200.
12. McCaffrey T.A., Fu C., Du B., Eksinar S., Kent K.C., Bush H., et al. High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. Journal of Clinical Investigation 2000, 105:653-662.
13. Mercer J., Bennett M. The role of p53 in atherosclerosis. Cell Cycle 2006, 5:1907-1909.
14. Nair P., Muthukkumar S., Sells S.F., Han S.S., Sukhatme V.P., Rangnekar V.M. Early growth response-1-dependent apoptosis is mediated by p53. Journal of Biological Chemistry 1997, 272:20131-20138.
15. Panini S.R., Sinensky M.S. Mechanisms of oxysterol-induced apoptosis. Current Opinion in Lipidology 2001, 12:529-533.
16. Park S.E., Lee S.W., Hossain M.A., Kim M.Y., Kim M.N., Ahn E.Y., et al. A chenodeoxycholic derivative, HS-1200, induces apoptosis and cell cycle modulation via Egr-1 gene expression control on human hepatoma cells. Cancer Letters 2008, 270:77-86.
17. Prunet C., Montange T., Véjux A., Laubriet A., Rohmer J.F., Riedinger J.M., et al. Multiplexed flow cytometric analyses of pro- and anti-inflammatory cytokines in the culture media of oxysterol-treated human monocytic cells and in the sera of atherosclerotic patients. Cytometry A 2006, 69:359-373.
18. Shin D.Y., Kim G.Y., Li W., Choi B.T., Kim N.D., Kang H.S., et al. Implication of intracellular ROS formation, caspase-3 activation and Egr-1 induction in platycodon D-induced apoptosis of U937 human leukemia cells. Biomedicine and Pharmacotherapy 2009, 63:86-94.
19. Yan S.F., Harja E., Andrassy M., Fujita T., Schmidt A.M. Protein kinase C beta/early growth response-1 pathway: a key player in ischemia, atherosclerosis, and restenosis. Journal of the American College of Cardiology 2006, 48:A47-A55.
20. Yu J., Baron V., Mercola D., Mustelin T., Adamson E.D. A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells. Cell Death and Differentiation 2007, 14:436-446.
21. Yuan X.M., Li W., Dalen H., Lotem J., Kama R., Sachs L., et al. Lysosomal destabilization in p53-induced apoptosis. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:6286-6291.
22. Yuan X.M., Osman E., Miah S., Zadeh S.N., Xu L., Forssell C., et al. p53 expression in human carotid atheroma is significantly related to plaque instability and clinical manifestations. Atherosclerosis 2010, 210:392-399.